106 related articles for article (PubMed ID: 1642855)
1. Susceptibility of strains of the Mycobacterium tuberculosis complex to fusidic acid.
Fuursted K; Askgaard D; Faber V
APMIS; 1992 Jul; 100(7):663-7. PubMed ID: 1642855
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of mycobacteria to fusidic acid.
Hoffner SE; Olsson-Liljequist B; Rydgård KJ; Svenson SB; Källenius G
Eur J Clin Microbiol Infect Dis; 1990 Apr; 9(4):294-7. PubMed ID: 2112466
[TBL] [Abstract][Full Text] [Related]
3. Detection of a streptomycin-resistant Mycobacterium bovis strain through antitubercular drug susceptibility testing of Tunisian Mycobacterium tuberculosis complex isolates from cattle.
Djemal SE; Camperio C; Armas F; Siala M; Smaoui S; Messadi-Akrout F; Gdoura R; Marianelli C
BMC Vet Res; 2018 Sep; 14(1):296. PubMed ID: 30268120
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the E test and a proportion dilution method for susceptibility testing of Mycobacterium tuberculosis.
Fabry W; Schmid EN; Ansorg R
Zentralbl Bakteriol; 1995 Oct; 282(4):394-401. PubMed ID: 9810662
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the in vitro activities of rifapentine and rifampicin against Mycobacterium tuberculosis complex.
Bemer-Melchior P; Bryskier A; Drugeon HB
J Antimicrob Chemother; 2000 Oct; 46(4):571-6. PubMed ID: 11020254
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of linezolid against Mycobacterium tuberculosis complex, including multidrug-resistant Mycobacterium bovis isolates.
Tato M; de la Pedrosa EG; Cantón R; Gómez-García I; Fortún J; Martín-Davila P; Baquero F; Gomez-Mampaso E
Int J Antimicrob Agents; 2006 Jul; 28(1):75-8. PubMed ID: 16774814
[TBL] [Abstract][Full Text] [Related]
7. Activity of rifapentine and its metabolite 25-O-desacetylrifapentine compared with rifampicin and rifabutin against Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis and M. bovis BCG.
Rastogi N; Goh KS; Berchel M; Bryskier A
J Antimicrob Chemother; 2000 Oct; 46(4):565-70. PubMed ID: 11020253
[TBL] [Abstract][Full Text] [Related]
8. Conventional and molecular determination of drug resistance in Mycobacterium tuberculosis and Mycobacterium bovis isolates in cattle.
Sweetline Anne N; Ronald BSM; Senthil Kumar TMA; Thangavelu A
Tuberculosis (Edinb); 2019 Jan; 114():113-118. PubMed ID: 30711149
[TBL] [Abstract][Full Text] [Related]
9. In vitro activities of levofloxacin used alone and in combination with first- and second-line antituberculous drugs against Mycobacterium tuberculosis.
Rastogi N; Goh KS; Bryskier A; Devallois A
Antimicrob Agents Chemother; 1996 Jul; 40(7):1610-6. PubMed ID: 8807049
[TBL] [Abstract][Full Text] [Related]
10. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
Akselband Y; Cabral C; Shapiro DS; McGrath P
J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of drug susceptibility of multi-drug resistant strains of Mycobacterium tuberculosis by ethambutol and dimethyl sulphoxide.
Jagannath C; Reddy VM; Gangadharam PR
J Antimicrob Chemother; 1995 Mar; 35(3):381-90. PubMed ID: 7782254
[TBL] [Abstract][Full Text] [Related]
12. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis.
Foroumadi A; Soltani F; Moshafi MH
Boll Chim Farm; 2002; 141(5):394-6. PubMed ID: 12481384
[TBL] [Abstract][Full Text] [Related]
13. Resistance to antituberculosis drugs in rural South Africa: rates, patterns, risks, and transmission dynamics.
Wilkinson D; Pillay M; Davies GR; Sturm AW
Trans R Soc Trop Med Hyg; 1996; 90(6):692-5. PubMed ID: 9015521
[TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibility of Mycobacterium tuberculosis to fusidic acid.
Cicek-Saydam C; Cavusoglu C; Burhanoglu D; Hilmioglu S; Ozkalay N; Bilgic A
Clin Microbiol Infect; 2001 Dec; 7(12):700-2. PubMed ID: 11843915
[TBL] [Abstract][Full Text] [Related]
15. Drug susceptibility in Mycobacterium tuberculosis of a sample of patients in Guinea Bissau.
Dias F; Michael SG; Hoffner SE; Martins L; Norberg R; Källenius G
Tuber Lung Dis; 1993 Apr; 74(2):129-30. PubMed ID: 8324205
[TBL] [Abstract][Full Text] [Related]
16. Two groups of Mycobacterium avium complex strains determined according to the susceptibility to rifampicin and ansamycin.
Tsukamura M
Microbiol Immunol; 1987; 31(7):615-23. PubMed ID: 3125413
[TBL] [Abstract][Full Text] [Related]
17. Activity of 16 antimicrobial agents against drug-resistant strains of Mycobacterium tuberculosis.
Fattorini L; Iona E; Ricci ML; Thoresen OF; Orrù G; Oggioni MR; Tortoli E; Piersimoni C; Chiaradonna P; Tronci M; Pozzi G; Orefici G
Microb Drug Resist; 1999; 5(4):265-70. PubMed ID: 10647084
[TBL] [Abstract][Full Text] [Related]
18. Comparative in-vitro activities of ten fluoroquinolones and fusidic acid against Mycobacterium spp.
Van Caekenberghe D
J Antimicrob Chemother; 1990 Sep; 26(3):381-6. PubMed ID: 2228828
[TBL] [Abstract][Full Text] [Related]
19. Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.
De Logu A; Onnis V; Saddi B; Congiu C; Schivo ML; Cocco MT
J Antimicrob Chemother; 2002 Feb; 49(2):275-82. PubMed ID: 11815568
[TBL] [Abstract][Full Text] [Related]
20. Spectrum of activity, mutation rates, synergistic interactions, and the effects of pH and serum proteins for fusidic acid (CEM-102).
Biedenbach DJ; Rhomberg PR; Mendes RE; Jones RN
Diagn Microbiol Infect Dis; 2010 Mar; 66(3):301-7. PubMed ID: 20159376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
